Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Biochemistry

• Publication date

  1997-11-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI9712091PMID 9374866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix degrading metalloproteinases

  2005cited by this paper
• Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies.

  1996cited by this paper
• MOLMOL: a program for display and analysis of macromolecular structures.

  1996cited by this paper
• Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallography

  1996cited by this paper
• The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation

  1996cited by this paper
• Localizing the NADP+ binding site on the MurB enzyme by NMR

  1996cited by this paper
• Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzyme

  1995cited by this paper
• Tissue inhibitors of matrix metalloendopeptidases.

  1995cited by this paper
• Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor

  1995cited by this paper
• Proteolytic remodeling of extracellular matrix.

  1995cited by this paper
• Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor

  1994cited by this paper
• Inhibition of human stromelysin by peptides based on the N-terminal domain of tissue inhibitor of metalloproteinases-1.

  1994cited by this paper
• Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family.

  1994cited by this paper
• Functional domains of human TIMP-1 (tissue inhibitor of metalloproteinases).

  1994cited by this paper
• 1.56 Å structure of mature truncated human fibroblast collagenase

  1994cited by this paper
• The X‐ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.

  1994cited by this paper
• Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.

  1994cited by this paper
• Structure of human neutrophil collagenase reveals large S1′ specificity pocket

  1994cited by this paper
• Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor.

  1994cited by this paper
• Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22.

  1994cited by this paper
• OB(oligonucleotide/oligosaccharide binding)‐fold: common structural and functional solution for non‐homologous sequences.

  1993cited by this paper
• Chemical modification of tissue inhibitor of metalloproteinases-1 and its inactivation by diethyl pyrocarbonate.

  1993cited by this paper
• Assignments for the main-chain nuclear magnetic resonances and delineation of the secondary structure of the catalytic domain of human stromelysin-1 as obtained from triple-resonance 3D NMR experiments.

  1993cited by this paper
• Secondary structure and zinc ligation of human recombinant short-form stromelysin by multidimensional heteronuclear NMR.

  1993cited by this paper
• The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.

  1993cited by this paper
• The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases.

  1992cited by this paper
• Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13.

  1992cited by this paper
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper
• Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated form.

  1991cited by this paper
• The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity.

  1991cited by this paper
• Relationship between nuclear magnetic resonance chemical shift and protein secondary structure.

  1991cited by this paper
• Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP).

  1990cited by this paper
• cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases.

  1990cited by this paper
• L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer

  1985cited by this paper
• Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity

  1985cited by this paper

• Structural determinants underlying the supramolecular binding between carborane and proteins in water.

  2025cites this paper
• Calmodulin binding is required for calcium mediated TRPA1 desensitization

  2025cites this paper
• Differentiating the solution structures and stability of transthyretin tetramer complexed with tolcapone and tafamidis using SEC-SWAXS and NMR

  2025cites this paper
• Mapping Antibody Epitopes by Solution NMR Spectroscopy: Practical Considerations.

  2025cites this paper
• The Bifunctional Effects of Lactoferrin (LFcinB11) in Inhibiting Neural Cell Adhesive Molecule (NCAM) Polysialylation and the Release of Neutrophil Extracellular Traps (NETs)

  2024cites this paper
• Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discovery

  2023cites this paper
• Identification, binding, and structural characterization of single domain anti-PD-L1 antibodies inhibitory of immune regulatory proteins PD-1 and CD80

  2022cites this paper
• Automated Determination of Nuclear Magnetic Resonance Chemical Shift Perturbations in Ligand Screening Experiments: The PICASSO Web Server

  2021cites this paper
• Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace

  2021cites this paper
• Cryo-EM structure of human Pol κ bound to DNA and mono-ubiquitylated PCNA

  2021cites this paper
• Conformational dynamics in interleukin 17A and 17F functional complexes is a key determinant of receptor A affinity and specificity.

  2021cites this paper
• Fusidic acid resistance through changes in the dynamics of the drug target

  2020cites this paper
• Molecular basis of P[II] major human rotavirus VP8* domain recognition of histo-blood group antigens

  2020cites this paper
• Stability and Strain in Hisactophilin and Mechanism of the Myristoyl Switch

  2019cites this paper
• Molecular basis of P[6] and P[8] major human rotavirus VP8* domain interactions with histo-blood group antigens

  2019cites this paper
• A Novel Mechanism for Calmodulin-Dependent Inactivation of Transient Receptor Potential Vanilloid 6.

  2018cites this paper
• Structural and functional analysis of Dickkopf 4 (Dkk4): New insights into Dkk evolution and regulation of Wnt signaling by Dkk and Kremen proteins

  2018cites this paper
• Mapping Antibody Epitopes by Solution NMR Spectroscopy: Practical Considerations.

  2018cites this paper
• Sin3A recruits Tet1 to the PAH1 domain via a highly conserved Sin3-Interaction Domain

  2018cites this paper
• Kinetic and Structural Characterization of the Effects of Membrane on the Complex of Cytochrome b5 and Cytochrome c

  2017cites this paper
• Probing the interaction between cHAVc3 peptide and the EC1 domain of E-cadherin using NMR and molecular dynamics simulations

  2017cites this paper
• Comprehensive structural analysis of designed incomplete polypeptide chains of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus

  2017cites this paper
• Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16)

  2016cites this paper
• Metal binding to the N-terminal cytoplasmic domain of the PIB ATPase HMA4 is required for metal transport in Arabidopsis

  2016cites this paper
• Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14*

  2016cites this paper
• Protein–Ligand Screening by NMR

  2016cites this paper
• A target-protection mechanism of antibiotic resistance at atomic resolution: insights into FusB-type fusidic acid resistance

  2016cites this paper
• Structure of a Potential Therapeutic Antibody Bound to IL-16: Mechanistic Insights and New Therapeutic Opportunities

  2016cites this paper
• On the interaction of Helicobacter pylori NikR, a Ni(II)-responsive transcription factor, with the urease operator: in solution and in silico studies

  2015cites this paper
• Functional and Structural Study of Vpu from HIV-1 by Nuclear Magnetic Resonance Spectroscopy

  2015cites this paper
• Structure and regulatory role of the C-terminal winged helix domain of the archaeal minichromosome maintenance complex

  2015cites this paper
• Effects of Membrane Mimetics on Cytochrome P450-Cytochrome b5 Interactions Characterized by NMR Spectroscopy*

  2015cites this paper
• Structural, ligand binding and redox studies of hPDI fragments using NMR spectroscopy

  2015cites this paper
• Epitope mapping by solution NMR spectroscopy

  2015cites this paper
• Biophysical characterization of interactions between the C-termini of peripheral nerve claudins and the PDZ₁ domain of zonula occludens.

  2015cites this paper
• NMR studies of interactions between Bax and BH3 domain-containing peptides in the absence and presence of CHAPS.

  2014cites this paper
• Protein Disulfide-Isomerase Interacts with a Substrate Protein at All Stages along Its Folding Pathway

  2014cites this paper
• Non-conserved C-terminal regions in the histone recognition module CW, determines specificity, stability and affinity towards monomethylated histone tails

  2014cites this paper
• Structural Insights into Interaction betweenMammalian Methionine Sulfoxide Reductase B 1 and Thioredoxin

  2014cites this paper
• Structural and biochemical studies of Sporosarcina pasteurii UreE: a nickel-chaperone involved in the urease activation process

  2014cites this paper
• Modern NMR Techniques for Synthetic Chemistry

  2014cites this paper
• Theoretical and experimental restraints to drive the docking of protein-protein complexes

  2014cites this paper
• Molecular landscape of the interaction between the urease accessory proteins UreE and UreG.

  2014cites this paper
• Conformational Heterogeneity in Antibody-Protein Antigen Recognition

  2014cites this paper
• The discovery, engineering and characterisation of a highly potent anti-human IL-13 fab fragment designed for administration by inhalation.

  2013cites this paper
• Halide and proton binding kinetics of yellow fluorescent protein variants.

  2013cites this paper
• Structure and Interactions of the Human Programmed Cell Death 1 Receptor*

  2013cites this paper
• Structure-Guided Design Affirms Inhibitors of Hepatitis C Virus p7 as a Viable Class of Antivirals Targeting Virion Release

  2013cites this paper
• Structural Characterisation of Antibody/Antigen Interactions: Implications for B-Cell Receptor Signalling

  2013cites this paper
• Structural and functional characterisation of Dickkopf4 (Dkk4), a key inhibitor of Wnt signalling

  2013cites this paper
• Etude fonctionnelle et évolutive de la voie de l'acide rétinoique et de la phosphorylation des récepteurs chez le poisson zèbre

  2013cites this paper
• Comparisons of Solution Structures of Free and IL-1β bound Fab Suggests a Model for B Cell Receptor Signalling

  2013cites this paper
• Using chemical shift perturbation to characterise ligand binding.

  2013cites this paper
• Structure and sigma factor interactions of M . tuberculosis RbpA 1 Mycobacterium tuberculosis RNA polymerase binding protein

  2013cites this paper
• Mycobacterium tuberculosis RNA Polymerase-binding Protein A (RbpA) and Its Interactions with Sigma Factors*

  2013cites this paper
• Structural Insights into Interaction between Mammalian Methionine Sulfoxide Reductase B1 and Thioredoxin

  2012cites this paper
• High-resolution NMR studies of structure and dynamics of human ERp27 indicate extensive inter-domain flexibility

  2012cites this paper
• High-resolution NMR studies of structure and dynamics of human ERp27 indicate extensive interdomain flexibility

  2012cites this paper
• Interaction of the Transactivation Domain of B-Myb with the TAZ2 Domain of the Coactivator p300: Molecular Features and Properties of the Complex

  2012cites this paper
• The N-terminus of the human RecQL4 helicase is a homeodomain-like DNA interaction motif

  2012cites this paper
• Structural, biochemical, and functional characterization of the cyclic nucleotide binding homology domain from the mouse EAG1 potassium channel.

  2012cites this paper
• Ribosome clearance by FusB-type proteins mediates resistance to the antibiotic fusidic acid

  2012cites this paper
• Ligands turning around in the midst of protein conformers: the origin of ligand-protein mating. A NMR view.

  2011cites this paper
• Structural and Dynamic Information on Ligand Binding

  2011cites this paper
• Structure–function relationship in an archaebacterial methionine sulphoxide reductase B

  2011influential citation
• Role of steric effects in protein-directed enediyne cycloaromatization of neocarzinostatin.

  2011cites this paper
• Structural basis for the broad specificity to host-cell ligands by the pathogenic fungus Candida albicans

  2011cites this paper
• Human Glutaminase Interacting Protein (GIP): a Potential Candidate for Anti-Cancer Drug Design

  2011cites this paper
• Studies of fibrinogen and fibronectin binding to a Staphylococcus aureus surface protein

  2011cites this paper
• Structure, dynamics, and RNA interaction analysis of the human SBDS protein.

  2010cites this paper
• Nucleic Acids Research

  2010cites this paper
• Metalloproteinase Inhibitors: Status and Scope from Marine Organisms

  2010influential citation
• Refolding of TIMP-2 from Escherichia coli inclusion bodies.

  2010cites this paper
• Constraining binding hot spots: NMR and molecular dynamics simulations provide a structural explanation for enthalpy-entropy compensation in SH2-ligand binding.

  2010cites this paper
• The interaction of protein disulfide isomerase with a substrate protein at different stages along its folding pathway

  2010cites this paper
• Vinexinβ, an atypical “sensor” of retinoic acid receptor γ signaling: union and sequestration, separation, and phosphorylation

  2010cites this paper
• Vinexin (cid:1) , an atypical “sensor” of retinoic acid receptor (cid:2) signaling: union and sequestration, separation, and phosphorylation

  2010cites this paper
• Discovery and Binding Studies on a Series of Novel Pin1 Ligands

  2009cites this paper
• Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3.

  2009cites this paper
• Formation of the complex between DsbD and PilB N-terminal domains from Neisseria meningitidis necessitates an adaptability of nDsbD.

  2009cites this paper
• High Resolution NMR-based Model for the Structure of a scFv-IL-1β Complex

  2009cites this paper
• Solution structure of interleukin-1β bound to a potential therapeutic antibody

  2009cites this paper
• 15N-1H scalar coupling perturbation: an additional probe for measuring structural changes due to ligand binding.

  2009cites this paper
• Characterization of the Structural Features and Interactions of Sclerostin

  2009cites this paper
• Probing the structure and function of human glutaminase-interacting protein: a possible target for drug design.

  2008cites this paper
• Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols.

  2008cites this paper
• Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR

  2008cites this paper
• Analyse structurale et dynamique par RMN des domaines N-terminaux des protéines DsbD et PilB de Neisseria meningitidis et de leur interaction

  2008cites this paper
• Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis.

  2008cites this paper
• p 160 / SRC / NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID / AD 1 domain

  2008cites this paper
• p160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain

  2008cites this paper
• Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A

  2007cites this paper
• Protein–Small Molecule Interactions in Neocarzinostatin, the Prototypical Enediyne Chromoprotein Antibiotic

  2007cites this paper
• Three dimensional structure and implications for the catalytic mechanism of 6-phosphogluconolactonase from Trypanosoma brucei.

  2007cites this paper
• Matrix Metalloproteinases and Their Tissue Inhibitors in Preterm Perinatal Complications

  2007cites this paper
• Studies of protein structure, dynamics and protein-ligand interactions using NMR spectroscopy

  2007cites this paper
• 1H, 13C and 15N resonance assignment of the oxidized form (Cys67–Cys70) of the N-terminal domain of PilB from Neisseria meningitidis

  2007cites this paper
• Solution structure and backbone dynamics of the reduced form and an oxidized form of E. coli methionine sulfoxide reductase A (MsrA): structural insight of the MsrA catalytic cycle.

  2007cites this paper
• A general algorithm for peak-tracking in multi-dimensional NMR experiments

  2007cites this paper
• NS3 Peptide, a Novel Potent Hepatitis C Virus NS3 Helicase Inhibitor: Its Mechanism of Action and Antiviral Activity in the Replicon System

  2007cites this paper